FDA approves drug that fights MS
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
564004
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
305568
Synthetic form of a sea-snail venom was approved Tuesday by the Food and Drug Administration as a novel approach to treating severe pain.
182674
Is a new MS drug going to be a top seller or a bottom-dweller? Here's how to find out.
69816
Tylenol (acetaminophen), Motrin (ibuprofen), and prednisone are equally effective against the flu-like syndrome that can arise in multiple sclerosis (MS) patients treated with interferon, new research suggests.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
594161
Genzyme announces positive study results with a recently acquired drug.
59092
The FDA, which has been under criticism for its lengthy approval process, this week approved two new drugs for multiple sclerosis and cancer treatment.
176876
Drugs given to patients with multiple sclerosis can reduce brain tissue loss and slow down the progression of the illness, scientists said on Friday.
508502
WASHINGTON - The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
553739
Multiple Sclerosis drugs can reduce brain tissue loss and slow down the progression of the illness. That&#39;s according to a team of researchers from Italy.
289071
Today was a day of good news for multiple sclerosis patients: FDA granted approval to a new anti-multiple sclerosis drug Antegren developed by Biogen Idec Inc.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
133355
Biogen Idec Inc. and Elan Corp. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn's disease.
555063
NEW YORK  - Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the US Food and Drug Administration (news - web sites) (FDA (news - web sites)) for the treatment of
134401
A drug currently prescribed to combat advanced breast cancer can now be used to help prevent the disease from recurring in women who have been treated for early forms of the disease, the US Food and Drug Administration ruled Friday.